The advertisement promotes VYVGART and VYVGART HYTRULO as the leading FDA-approved biologic treatments for adults with anti-AChR antibody positive gMG, highlighting important safety information and potential risks.
Creative Information
| CID: | b06f90e2-6cac-490c-835a-bab5439c20fb |
| CRID: | 82_5970-961555 |
| Domain: | vyvgarthcp.com |
| Seat: | PP |
| Size: | 300x600 |
| Bid: | $2.30 |
| Timestamp: | 11/7/2025, 2:38:01 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/7/2025, 4:32:23 PM | 7.19s | |
| adomain_analysis | success | 11/7/2025, 6:28:09 PM | 3.46s | |
| adomain_capture | success | 11/7/2025, 6:27:57 PM | 0.09s | |
| ad_render | success | 11/7/2025, 4:32:16 PM | 24.23s | |
| brand_mapping | success | 11/7/2025, 2:38:01 PM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: VYVGART Hytrulo
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 930.27 KB | ||||||||||||||||||||||
| Render Time: | 8.79 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 930.40 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

